RESULTS: From 2004 to 2009, 4,910 patients (3,107 UW and 1,803 CS) with sufficient preservation solution information for analysis underwent OHT. Baseline characteristics were well-matched between the two groups. UW was associated with a small but significantly improved survival compared with CS at 30 days (96.7% vs 95.4%, p = 0.02)
and 1- year (89.6% vs 87.0%, p < 0.01). These survival differences persisted on multivariate analysis at 30 days (HR 1.47 [1.02 to 2.13], p < 0.05) and 1 year (HR 1.40 [1.14 to 1.73], p < 0.01). In the 1,455 patients with high-risk allografts, preservation with UW was associated with improved survival compared with CS at 30 days (94.3% vs 91.3%, p < 0.01) and at I year S63845 in vivo (84.2% vs 80.19%, p < 0.01), a difference that was significant according to multivariate Cox analysis at 30 days (HR 2.29 [1.39 to 3.76], p < 0.01) and 1 year (HR 1.61 [1.17 to 2.21], p < 0.01).
CONCLUSIONS: Preservation with UW solution is associated with improved short-term survival compared with CS. Patients undergoing OHT with high-risk allografts have a similar survival benefit. Heart Lung Transplant 2011;30:1033-43 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.”
“Coupling luminescent solar concentrators (LSC) with plasmonic solar cells is a potential method to increase
conversion efficiency while reducing cost associated with large-area photovoltaic and solar-tracking systems. Specifically, the emission spectrum of the fluorescent dye in the LSC can be matched to the absorption spectrum in the Selleckchem CP 456773 photovoltaic cell which can be tuned by surface plasmon resonance. Here we investigate this concept employing organic solar cells with plasmonic silver nanoparticles and polymethylmethacrylate-based solar concentrators
with Lumogen Red dye. The absorption enhancement is predicted by Mie theory, taking size effect on dielectric properties into EPZ5676 inhibitor consideration. A factor of two increase of conversion efficiency is obtained when the absorption peak in the solar cell is tuned to match the emission peak of Lumogen Red dye. A similar approach could be employed to enhance the efficiency of other LSC-photovoltaic systems including those based on silicon solar cells with different surface plasmonic nanostructures. (C) 2011 American Institute of Physics. [doi: 10.1063/1.3567928]“
“Objective. The objective of this study was to evaluate whether hydroxychloroquine (HCQ) therapy effects subjective and/or objective complaints and salivary flow rates of patients with primary Sjogren’s syndrome (PSS).
Study design. Thirty women recently diagnosed with PSS, scheduled for HCQ treatment (400 mg daily), participated and were clinically examined before initiation of 30 weeks of HCQ treatment. During baseline evaluation, both the objective and/or subjective oral findings were recorded.